BRIEF-GSK's lung drug gains approval in Japan
December 02, 2016 at 02:11 AM EST
* Relvar Ellipta 100/25 mcg gains approval in Japan for use in patients with COPD
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.